HomeMDNAF • OTCMKTS
add
Medicenna Therapeutics Corp
Previous close
$1.03
Day range
$0.95 - $1.03
Year range
$0.30 - $2.20
Market cap
107.16M CAD
Avg Volume
71.00K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.53M | 1.66% |
Net income | -4.16M | -11.85% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.52M | -1.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.43M | 18.45% |
Total assets | 32.93M | 18.69% |
Total liabilities | 12.88M | 199.05% |
Total equity | 20.05M | — |
Shares outstanding | 78.16M | — |
Price to book | 3.96 | — |
Return on assets | -38.95% | — |
Return on capital | -64.10% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.16M | -11.85% |
Cash from operations | -5.61M | -43.15% |
Cash from investing | -2.00K | — |
Cash from financing | 706.00K | — |
Net change in cash | -5.20M | -32.46% |
Free cash flow | -15.04M | -257.61% |
About
Founded
2015
Headquarters
Website
Employees
16
